By AMERICAN HEART ASSOCIATION NEWS

A highly anticipated study has found that the new cholesterol-lowering drug evolocumab can reduce heart attacks and strokes among high-risk patients.

The findings, published last week in the New England Journal of Medicine and presented at the American College of Cardiology’s annual meeting, showed that the […]